The findings suggest that once the Th17 cells have expanded in the lungs or nasal tissue during primary infection, unlike in Il17A−/− mice, anti-IL-17 treatment before and after re-challenge with B. pertussis does not affect the frequency of the IL-17- relative to IFN-γ-secreting T cells in the respiratory tissue. This evidence concerns the gene IFNG and infection.